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Michelle Woldemar Carr, Ronen Alon, known as chemokines. The chemokines include the C±C
chemokines such as MCP-1, RANTES, MIP-1a,and MIP-and Timothy A. Springer
1b, which primarily attract monocytes and T lym-The Center for Blood Research
phocytes, and the C±X±C chemokines such as interleu-and Harvard Medical School
kin-8 (IL-8) and the gro proteins that primarily attractDepartment of Pathology
neutrophils (Baggiolini et al., 1994). There is some evi-Boston, Massachusetts 02115
dence that chemoattractants may play a role in activat-
ing integrins expressed on lymphocytes, as well as neu-
trophils. First, it has been shown that pertussis toxinSummary
inhibits the firm arrest and transmigration of T lympho-
cytes into inflammatory sites in vivo (Bargatze andThe ability of chemokines, particularly MCP-1, to in-
Butcher, 1993; Spangrude et al., 1985). This implicatesduce integrin-dependent binding of T lymphocytes to
a G protein±coupled signaling event in lymphocyte ad-endothelial adhesion molecules or extracellular matrix
hesion and extravasation and suggests a role for chem-(ECM) components was examined. MCP-1 induced
oattractants, since all chemoattractant receptors thussignificant adhesion to fibronectin (FN) and to endo-
far identified couple to G proteins (Gerard and Gerard,
thelial-secreted ECM but not to purified ICAM-1 or
1994; Murphy, 1994). Moreover, several chemokines
VCAM-1, or to activated endothelium. The MCP-1- have been shown to up-regulate lymphocyte adhesion
induced binding of T lymphocytes to FN was rapid, to endothelial cells or isolated endothelial ligands (Taub
dose dependent, and resulted from activation of both et al., 1993a, 1993b; Tanaka et al., 1993b), although
VLA-4 and VLA-5. Like MCP-1, the chemokines these proadhesive effects were relatively small and re-
RANTES and MIP-1b induced T lymphocyte binding to quired relatively long incubation times.
FN, but not to ICAM-1. We suggest, therefore, that Interestingly, while both neutrophils and T lympho-
these T lymphocyte chemokines may be most impor- cytes express b2 integrins that bind to ICAM-1 and
tant, not in initiating integrin-dependent firm adhesion ICAM-2 expressed on vascular endothelium, T lympho-
of T lymphocytes to the vascular wall, but rather, in cytes also express the b1 integrin, VLA-4, which binds
subsequent adhesive interactions during migration to VCAM-1, expressed on stimulated endothelium, as
into tissue. well as fibronectin (FN) expressed in the subendothelial
ECM (Hemler, 1990). Thus, unlike most neutrophils,
which lack VLA-4 and bind endothelium solely throughIntroduction
b2 integrin±mediated interactions with ICAM-1, T lym-
phocytes can bind endothelium using either b1 integrin±Transendothelial migration of leukocytes into sites of
mediated (VLA-4 binding to VCAM-1) or b2 integrin±inflammation isa multistep process mediated by a series
mediated (LFA-1 binding to ICAM-1 and ICAM-2)of sequential but overlapping interactions (Springer,
interactions. VLA-4 expressed on T lymphocytes has1995). In this process, leukocytes in hemodynamic flow
also been found to mediate tethering, rolling, and arresttether to and roll along the endothelium of a vessel wall,
of T lymphocytes on VCAM-1 (Jones et al., 1994; Alonpotentially encountering activating factors that modu-
et al., 1995; Luscinskas et al., 1995; Berlin et al., 1995).late integrin-dependent firm adhesion and arrest of the
While VLA-4 likely works in concert with selectins androlling leukocyte on thevessel wall. Following directional
b2 integrins to mediate lymphocyte rolling and arrest incues from chemoattractants and using integrin mole-
vivo (Bargatze et al., 1995), the ability of VLA-4 to medi-cules for traction, leukocytes then cross the endothelial
ate spontaneous arrest allows T lymphocytes potentiallylining of the blood vessel, traverse through the underly-
to bypass the need for chemoattractant-induced firm
ing extracellular matrix (ECM), and enter inflamed tissue.
adhesion, although a chemoattractant would likely still
While this model for leukocyte extravasation is widely
be needed to provide directional cues for transendothe-
accepted for neutrophils, it remains to be determined lial migration. Thus, the presence of VLA-4 on lympho-
which of these steps are applicable to T lymphocyte cytes, but not neutrophils, opens the possibility that the
emigration from the bloodstream. Particular ambiguity signals for integrin activation on these two cell types
concerns the identity of the signal(s) needed to activate might differ significantly.
the integrins on T lymphocytes. Strong evidence exists We have previously demonstrated that MCP-1 acts
that chemoattractants can provide the signals that mod- as a major chemoattractant of T lymphocytes in vitro
ulate the avidity of integrins on neutrophils (Springer, (Carr et al., 1994). In the experiments presented here,
1995); however, much less is known about the role of we investigate the role of MCP-1, and other C±C chemo-
these attractant molecules in triggering integrin activa- kines, in activating T lymphocyte integrins, using a novel
tion on lymphocytes. and highly sensitive adhesion assay employing a parallel
In the past several years, a number of T lymphocyte plate flow chamber and controlled detachment condi-
chemoattractants have been identified (Schall et al., tions. Results demonstrate that MCP-1 induces signifi-
1990, 1993; Taub et al., 1993a, 1993b, 1995; Tanaka et cant integrin-mediated T lymphocyte adhesion to the
al., 1993a, 1993b; Carr et al., 1994; Loetscher et al., ECM protein FN and to endothelial-secreted ECM. In
1994; Adams et al., 1994). Many of these attractants contrast, under the same conditions, MCP-1 fails to in-
duce statistically significant binding to purified ICAM-1belong to a family of 8±10 kDa, heparin-binding proteins
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or cytokine-stimulated endothelium. MCP-1 also fails to of MCP-1-stimulated T lymphocytes remained firmly
bound to FN, even at very high shear stresses, indicatingaugment binding to VCAM-1, perhaps owing to the high
constitutive binding of T lymphocytes to purified VCAM- a strong adhesive interaction. A small fraction of unstim-
ulated T lymphocytes also demonstrated shear-resis-1. Therefore, we propose that MCP-1 and other C±C
chemokines may be less important for integrin-depen- tant binding to FN, which suggests the presence of a
subset of cells with constitutive FN-binding activitydent firm adhesion of T lymphocytes to the vascular wall
than for adhesion during or following transendothelial within this population of resting T lymphocytes. In con-
trast, using identical flow conditions, in the presence ofmigration into tissue.
MCP-1 there was on average only a modest increase in
T lymphocyte binding to ICAM-1 over the range of shear
Results forces studied (Figure 1B). The effects on binding to
ICAM-1 were not seen in all experiments and were not
MCP-1 Differentially Induces T Lymphocyte statistically significant. These results were further veri-
Adhesion to FN Compared with fied by performing the controlled detachment assays at
ICAM-1 or VCAM-1 378C, for varying incubation periods, or using variable
In preliminary experiments using a traditional static ad- ICAM-1 concentrations; again, MCP-1 was found to
hesion assay (Diamond et al., 1990), we examined the have no statistically significant effect on T lymphocyte
ability of MCP-1 to induce integrin-dependent binding binding to ICAM-1 (data not shown). Phorbol myristate
of T lymphocytes to purified preparations of the vascular acetate (PMA) was included as a positive control for
ligands ICAM-1 and VCAM-1 or to cytokine-stimulated stimulated binding to the substrate in all experiments.
human umbilical vein endothelial cell (HUVEC). Despite The binding of PMA-stimulated T lymphocytes to
gentle washing conditions, soluble MCP-1 at a wide ICAM-1 typically ranged from approximately 45%±25%
range of concentrations and incubation times was found over the range of shears tested. When ICAM-1 binding
to have no effect on T lymphocyte adhesion to either experiments were performed at 378C or for longer incu-
purified ligand or to the endothelium (data not shown). bation periods (>10 min), PMA-induced binding of T
Moreover, coimmobilization of MCP-1 on heparin± lymphocytes was increased to >60% at low shear stress
bovine serum albumin with ICAM-1 also failed to induce (data not shown). Dose-response curves for PMA stimu-
T lymphocyte binding to ICAM-1 (data not shown). In lation of binding to fibronectin and ICAM-1 were similar,
contrast, however, soluble MCP-1 was found to induce with near maximal stimulation of binding at 0.5 ng/ml
a small, but reproducible, increase in binding of T lym- and 1.5 ng/ml, respectively (data not shown).
phocytes to FN (data not shown). Unlike the low background binding of resting T lym-
More sensitive adhesion assays wereperformed using phocytes to FN or ICAM-1, the binding of resting T lym-
a parallel-plate flow chamber, which allowed controlled phocytes to VCAM-1 was very high and MCP-1 was not
detachment forces to be applied to adherent cells. Cells observed to augment further this constitutive binding at
were introduced into the chamber and allowed to bind any of the applied shears (Figure 1C). To test whether
in stasis to immobilized adhesion proteins. Cells were this high constitutive T lymphocyteadhesion was related
then subjected to incremental increases in flow shear, to the density of the VCAM-1 substrate, the concentra-
and the cells that remained bound were quantitated at tion of immobilized ligand was decreased. Interestingly,
each shear. All cellular interactions with the substrate while VCAM-1 titration resulted in decreased binding of
were recorded on videotape for later analysis. Unlike resting cells, there was still no detectable enhancing
static assays in which the only readout of adhesion is effect of MCP-1 on T lymphocyte binding (data not
the final number of cells remaining bound following ex- shown). Since VCAM-1 supports tethering in flow as well
posure to relatively high but poorly controlled and unde- as firm adhesion of T lymphocytes, we studied the ability
fined detachment forces, the parallel-plate flow assay of MCP-1 to modulate T lymphocyte binding to VCAM-1
allows the effects of MCP-1 to be monitored at the single in shear flow. MCP-1 had no effect on the number of
cell level at each shear applied. The incremental applica- cells that tethered to VCAM-1 at 1.0 dyne/cm2 (Figure
tion of known shear detachment forces permits subsets 1D), nor did MCP-1-stimulatedcells that tethered exhibit
of cells with low, medium, and high adhesion strengths any additional shear resistance (Figure 1d). Thus, while
to be readily monitored by their resistance to detach- MCP-1 was able to induce significant T lymphocyte
ment. Maximal MCP-1-induced binding to FN was found binding to FN, it was unable to stimulate significant
to occur between 4±7 min of stimulation; at later times, binding to ICAM-1, nor was it able to augment the high
the ratio of stimulated to resting T lymphocytes bound constitutive tethering and firm adhesion of T lympho-
to FN decreased, while at shorter times relatively fewer cytes to VCAM-1, even when these effects were studied
cells bound (data not shown). Based on these data, we in a highly sensitive controlled shear detachment assay.
chose to analyze the effects of MCP-1 on T lymphocyte
adhesion following 6.5 min of stimulation.
In experiments examining FN binding, MCP-1 was Characterization of the Effect of MCP-1
on T Lymphocyte Adhesion to FNfound to induce binding of greater than 15% of the T
lymphocytes, a 4- to 6-fold increase over resting cells The controlled shear detachment assay was used to
study MCP-1-induced T lymphocyte binding to FN in(Figure 1A). Some interactions between stimulated or
resting cells and FN were found to be relatively weak, further detail. T lymphocytes were stimulated with in-
creasing concentrations of MCP-1 and cells remainingas can be seen by the rapid detachment of a popula-
tion of cells at low shear stress. However, the majority bound at low (1.2 dyne/cm2), medium (6.0 dyne/cm2),
Differential Modulation of b1 and b2 Integrins
181
Figure 1. MCP-1 Induces Shear-Resistant
Binding of T Lymphocytes to Immobilized FN,
but Not ICAM-1 or VCAM-1 in a Controlled
Shear Detachment Assay
T lymphocytes with or without MCP-1 (100
ng/ml) or PMA (50 ng/ml) were flowed into a
parallel plate flow chamber and allowed to
attach to FN (A) (30 mg/ml), ICAM-1 (B) (30
mg/ml), or VCAM-1 (C) (20 mg/ml) under static
conditions at room temperature for 6.5 min or
(D) were allowed to attach to VCAM-1 under
physiologic flow conditions (1.0 dyne/cm2) for
6.5 min. Following attachment, flow was initi-
ated and increased in 2- to 2.5-fold incre-
ments every 10 s. Within an experiment, the
same field of view was used and all experi-
ments were recorded on videotape. The num-
ber of cells remaining bound at each interval
was determined by analysis of the videotape
and is expressed as the percentage of input
cells remaining bound. The data in (A) and (B)
is the average of at least three experiments
and error bars represent standard error of the
mean. Data in (C) and (D) are representative
of one of three experiments. PMA was in-
cluded as a positive control in each experi-
ment and was found to induce binding, over
the range of shears shown, which decreased from an average of 58.0%±52.3% on FN (A), 41.1%±24.3% on ICAM-1 (B), and 73.7%±69.1%
on VCAM-1 (C). Statistical analysis using a paired two-tailed student's t-test showed that MCP-1 stimulation induced statistically significant
binding (p < 0.05) to FN, but not to ICAM-1 or VCAM-1.
and high (22.5 dyne/cm2) shear stresses, representing MCP-1 failed to induce statistically significant binding
to ICAM-1 at any of the concentrations tested (data notcell populations bound with increasing strengths of ad-
shown).hesion, were analyzed. MCP-1 was found to induce
Since individual lymphocyte chemokines might be ca-dose-dependent T lymphocyte binding to FN (Figure 2).
pable of activating specific T lymphocyte subpopula-MCP-1-stimulated binding was statistically significant
tions, the effect of other C±C chemokines on T lympho-compared with binding of resting cells at 50 and 100
cyte binding to FN or ICAM-1 was analyzed andng/ml at the lower shears and at 100 ng/ml at higher
compared with binding induced by MCP-1. The chemo-shear. These concentrations are in agreement with con-
kines were tested at concentrations previously showncentrations that we have previously shown to induce
to induce significant levels of T lymphocyte transendo-maximal T lymphocyte transendothelial chemotaxis
thelial chemotaxis (S. J. Roth, M. W. C., and T. A. S.,(Carr et al., 1994). In contrast with the results on FN,
unpublished data). Thechemokine RANTES, like MCP-1,
was shown to induce a statistically significant increase
in binding of T lymphocytes to FN at all shears tested,
while MIP-1b induced a significant increase in binding
only at the medium and high shears (Figure 3A). In con-
trast, none of the C±C chemokines, MCP-1, RANTES,
MIP-1b, and also MIP-1a, induced a significant increase
in binding of T lymphocytes to ICAM-1 compared with
that of resting lymphocytes (Figure 3B). Thus, C±C
chemokines selectively induce b1 integrin±dependent
binding of T lymphocytes to FN but not b2 integrin±
dependent binding to ICAM-1. Moreover, the failure of
each of the chemokines to stimulate binding to ICAM-1
shows that the lack of b2 integrin activation is not spe-
cific to MCP-1.
Figure 2. MCP-1 Induces Concentration-Dependent Binding of T T lymphocytes use two integrins, VLA-4 and VLA-5,
Lymphocytes to FN in a Controlled Shear Detachment Assay to bind to FN. Monoclonal antibody (MAb) blocking ex-
Experiments were performed as in Figure 1 with MCP-1 added at periments were performed to determine whether MCP-1
the concentrations indicated. Representative low, medium, and high was preferentially activating one VLA over the other, or
shear stress are shown. PMA was included as a positive control whether both integrins were being activated. MAb to the
and induced 47.3%, 42.2%, and 36.1% binding at 1.2, 6, and 22.5
b1 subunit, shared by both VLA-4 and VLA-5, inhibited
dyne/cm2, respectively. Statistical analysis using a paired two-tailed
MCP-1-induced T lymphocyte binding to FN by greaterstudent's t-test showed that MCP-1 stimulation induced statistically
than 90%, as did MAbs to VLA-4 and VLA-5 when com-significant (p < 0.05) binding to FN at 50 and 100 ng/ml. Data are
bined (Figure 4). When used separately, MAbs to the athe average of three independent experiments. Error bars represent
SEM. chains of either VLA-4 or VLA-5 partially, but similarly,
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Figure 4. Antibodies to VLA-4 and VLA-5 Inhibit MCP-1-Induced
Binding of T Lymphocytes to FN in a Controlled Detachment Binding
Assay
Experiments were performed as described in Figure 1. MAbs (1:30
dilution of MAb 13, A4-PUJ1 and A5-PUJ1 ascites or 30 mg/ml of
purified R6.5, concentrations shown by FACS to be saturating) were
preincubated with cells for 10 min prior to addition of MCP-1 (100
ng/ml); antibody was included throughout the assay. Representative
low, medium, and high shear stresses are shown. PMA was included
as a positive control and induced 59.1%, 55.7%, and 54.8% binding
at 1.2, 6, and 22.5 dyne/cm2, respectively. Data are the average of
three independent experiments. Error bars represent SEM.
integrin affinity for FN, lymphocytes were preincubated
with cytochalasin B to disrupt actin microfilaments (Ya-
hara et al., 1982; Cooper, 1987). A high concentration
(20 mM) of cytochalasin B was found to abolish shear-
resistant MCP-1-induced adhesion of T lymphocytes to
FN (Figure 5). This concentration of cytochalasin B alsoFigure 3. C±C Chemokines Induce Shear Resistant Binding to FN,
slightly decreased the binding of resting T lymphocytesbut Not to ICAM-1, in a Controlled Detachment Binding Assay
to FN. However, a 10-fold lower concentration of cyto-Experiments were performed as in Figure 1 with the chemokines at
concentrations that had been previously found to induce significant chalasin B caused insignificant inhibition of T lympho-
T lymphocyte chemotaxis: MCP-1 and RANTES at 100 ng/ml and cyte adhesion in this assay. Interestingly, when identical
MIP-1a and MIP-1b at 10 ng/ml. PMA was included as a positive concentrations of cytochalasin B were included in che-
control and induced 66.6%, 59.5%, and 56.4% binding to FN (A)
motaxis assays, migration of T lymphocytes to MCP-1and 50.9%, 39.9%, and 27.2% binding to ICAM-1 (B) at 1.2, 6, and
was significantly inhibited by both concentrations of22.5 dyne/cm2, respectively. Representative low, medium, and high
cytochalasin B (M. W. C., unpublished data), suggestingshear stresses are shown. Statistical analysis using a paired two-
tailed student's t-test showed that MCP-1 and RANTES induced
significant adhesion to FN (p < 0.05) at each shear tested; MIP-1b
induced significant adhesion to FN only at the medium and high
shear stresses. None of the C±C chemokines induced significant
adhesion to ICAM-1. Data are the average of three independent
experiments. Error bars represent SEM.
inhibited MCP-1-induced T lymphocyte binding, sug-
gesting that both VLA-4 and VLA-5 are activated and
required for optimal stable binding to FN. These integrin
antibodies were also found to reduce the low level bind-
ing of resting cells (data not shown), indicating that con-
stitutive T lymphocyte binding to FN was b1 integrin
dependent. Immunofluorescent flow cytometry of T lym-
phocytes stimulated with MCP-1 for 10 min showed that
this binding was not due to increased expression of Figure 5. Cytochalasin B Inhibits MCP-1-Induced Binding of T Lym-
phocytes to FN in a Controlled Detachment Binding Assayeither VLA-4 or VLA-5 (data not shown). These results
Experiments were performed as described in Figure 1 using FN atwere further confirmed using peptides which block VLA-
30 mg/ml. Cytochalasin B (20 or 2.0 mM) was preincubated with cells5-dependent but not VLA-4-dependent adhesion to FN
for 30 min prior to addition of MCP-1 (100 ng/ml) and was included(Ferguson et al., 1991). RGD peptide was found to block
throughout the experiment. Cytochalasin B was also included inbinding to FN at levels similar to those observed in the
experiments with resting cells. The data presented here is represen-
presence of anti-VLA-5 antibody, while an RGE peptide tative of one of three independent experiments with similar results.
control had no effect (data not shown). Representative low, medium, and high shear stresses are shown.
To determine whether MCP-1 stimulation of T lympho- PMA was included as a positive control and induced 43.2%, 41.0%,
and 40.3% binding at 1.2, 6, and 22.5 dyne/cm2, respectively.cytes required an intact actin cytoskeleton to modulate
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Figure 7. Antibodies to VLA-4 and VLA-5 Inhibit MCP-1-Induced
Binding of T Lymphocytes to Subendothelial ECM in a Controlled
Detachment Binding Assay
Experiments were performed as described in Figure 1 using endo-
thelial matrix secreted by HUVEC cultured for 2 weeks, then deter-
gent solubilized. MAbs (1:30 dilution of antibody 13, A4-PUJ1 and
A5-PUJ1 ascites or 30 mg/ml of purified R6.5, concentrations shown
by FACS to be saturating) were preincubated with cells for 10 min
prior to addition of MCP-1 (100 ng/ml) and antibody was included
throughout the assay. Representative low, medium, and high shear
stresses are shown. PMA was included as a positive control and
induced 76%, 58%, and 40% binding at 1.2, 6, and 22.5 dyne/cm2,
respectively. Data are the average of three independent experi-
ments. Error bars represent SEM.
not shown). In other experiments, MCP-1-stimulated or
resting cells were allowed to tether to stimulated HUVEC
under physiologic flow conditions. MCP-1 was found to
have no augmenting effect on the shear resistance of
Figure 6. MCP-1 Fails to Augment Binding of T Lymphocytes to
these tethered cells (data not shown). Thus, even whenTNFa-Stimulated HUVEC but Does Induce Binding to Subendothel-
T lymphocytes were allowed first to form rolling adhe-ial ECM in a Controlled Detachment Binding Assay
sions on the HUVEC, stimulation by MCP-1 did not fur-Experiments were performed as described in Figure 1 using HUVEC
ther augment binding to the endothelium.(A) stimulated for 5 hr with 200 U/ml of TNFa orendothelial matrix (B)
secreted by HUVEC cultured for 2 weeks, then detergent solubilized. In parallel experiments, the effect of MCP-1 on T lym-
Data in (A) is representative of one of three independent experiments phocyte adhesion to HUVEC-secreted ECM was as-
with similar results, while data in (B) is an average of four indepen- sessed. Immunofluorescent staining of the ECM indi-
dent experiments. Representative low, medium, and high shear
cated that the major constituents were FN, laminin, andstresses are shown. PMA was included as a positive control and
several types of collagen (Roth et al., 1995). MCP-1 wasinduced 90.9%, 75%, and 54.5% binding to the HUVEC at 1.2, 6,
found to induce significant T lymphocytebinding toECMand 22.5dyne/cm2, respectively and 47.6%, 36.2%, and 25.4% bind-
ing to the ECM at the same respective shears. (Figure 6B). As was seen in binding experiments to puri-
fied FN, b1 integrin±blocking MAbs almost completely
inhibited binding to ECM, as did a combination of MAbs
to VLA-4 and VLA-5 (Figure 7), suggesting that FN is thethat migration is more dependent on the presence of a
fully intact actin cytoskeleton than is integrin-dependent major ligand involved in chemokine-induced T lympho-
cyte interactions with ECM. Moreover, these results onadhesion, and that MCP-1-dependent modulation of in-
tegrin adhesiveness and MCP-1-dependent chemotaxis ECM demonstrate MCP-1-induced T lymphocyte bind-
ing to a physiologically relevant naturally occurring sub-may operate through separate pathways.
strate.
Effects of MCP-1 on T Lymphocyte
Binding to Stimulated HUVEC Discussion
or HUVEC-Secreted ECM
Using the controlled shear detachment assay, MCP-1- The data presented here fail to support the widely ac-
cepted hypothesis that chemokines serve to activate Tinduced interactions between T lymphocytes and cyto-
kine-stimulated HUVEC, shown by immunofluorescent lymphocyte integrins in order to mediate firm binding
and arrest of lymphocytes on the vascular adhesionstaining to express high levels of ICAM-1, VCAM-1, and
E-selectin, were analyzed. Constitutiveadhesion of rest- proteins, ICAM-1 and VCAM-1, prior to migration into
surrounding tissue. These experiments do, however,ing T lymphocytes to stimulated HUVEC was high and
further stimulation with MCP-1 had no effect on shear- show a clear role for chemokines, particularly MCP-1,
in modulating lymphocyte adhesion to ECM proteinsresistant lymphocyte adhesion (Figure 6A). In contrast,
neither resting nor MCP-1-stimulated T lymphocytes secreted by endothelium, specifically FN. This
MCP-1-induced binding to FN was shown to be dosebound at significant levels to unstimulated HUVEC (data
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dependent and to occur rapidly, within 4±7 min of the idea that VLA-4 expressed on peripheral T lympho-
cytes exists in a partially active state. Addition of anexposure to the chemokine. Additional experiments
activator, such as MCP-1 or another chemokine, is re-demonstrated that MCP-1 activates both the VLA-4 and
quired to convert this VLA-4 into the fully active state,VLA-5 integrins, which together contribute to the MCP-
allowing T lymphocytes to firmly bind FN.1-dependent increase in T lymphocyte binding to FN.
MCP-1, under these conditions, had only modest orThis binding was dependent on the presence of an intact
no ability to activate the b2 integrin, LFA-1,as no statisti-cytoskeleton, suggesting that MCP-1 stimulation results
cally significant MCP-1-induced T lymphocyte bindingin postligand stabilization events that are required to
to the LFA-1 ligand, ICAM-1, was observed. Althoughmediate firm adhesion.
MCP-1 was found to have a modest activating effect onOur findings onHUVEC-secreted ECM are in agreement
LFA-1 in some experiments, this was not a consistentwith those presented in a recent paper in which RANTES
finding, since in other experiments MCP-1 had no effectand MIP-1b were found to induce binding of CD41 T
compared with control. This lack of effect does not ap-lymphocytes to subendothelial ECM (Gilat et al., 1994).
pear tobe due toan inability to find optimal T lymphocyteIn those experiments, however, a 30 min incubation with
binding conditions, since conditions that supported lym-chemokine was necessary to detect an adhesive effect;
phocyte binding to FN and VCAM-1 failed to supportthis is unlike our results in which soluble chemokine was
binding to ICAM-1. Experiments varying MCP-1 concen-found to activate b1 integrin±mediated adhesion in as
tration, ICAM-1 concentration, time of incubation, typelittle as 4 min. This shorter timepoint is presumably more
of chemokine, and assay temperature, all failed to showphysiologic than the 15±30 min incubations typically
chemokine-stimulated T lymphocyte binding to ICAM-1.used to measure lymphocyte adhesion in static binding
PMA stimulation did induce significant binding, indicat-assays (Taub et al., 1993a, 1993b; Tanaka et al., 1993b;
ing a suitable ICAM-1 substrate and activatable lympho-Gilat et al., 1994), since integrin-dependent adhesion
cytes. These findings suggest that the regulation of b2strengthening is believed to occur within minutes follow-
integrins differs between neutrophils and T lympho-ing stimulation (Springer, 1995).
cytes,with b2 integrins on neutrophils, butnot T lympho-The protein kinase C activator PMA induced both b1
cytes, being regulated by chemokines, at least with theand b2 integrin±dependent binding,although at subopti-
known T cell chemokines examined here. This differen-mal doses PMA activated VLA-4 and VLA-5 at slightly
tial response may be due, in part, to the high expression
lower concentrationsthan for LFA-1. In contrast, chemo-
of chemokine receptors on neutrophils (2±9 3 104 recep-
kines differentially induced b1 compared with b2 inte-
tors/cells) (Baggiolini et al., 1994), while receptors for
grin±dependent binding of T lymphocytes at all doses
C±C chemokines are difficult to detect on PBL (Napo-
examined. These findings suggest that integrins may
litano et al., 1990). Alternatively, the mechanism of
require distinct physiologic activation signals to interact
chemokine activation for Mac-1, the primary b2 integrin
with their respective ligands. However, we have not de- on neutrophils, may be inherently different than the
fined whether the underlying mechanism is attributable mechanism of chemokine activation for LFA-1, the pri-
to differential sensitivity of the integrins to signals in mary b2 integrin on T lymphocytes.
general or selective action of chemokine signaling path- These data, together with recently published data
ways on b1 as opposed to b2 integrins, both mecha- demonstrating the ability of T lymphocytes to tether,
nisms may contribute. As mentioned previously, our lab roll, and spontaneously arrest on VCAM-1 (Alon et al.,
and others have shown that T lymphocytes can interact 1995; Berlin et al., 1995; Jones et al., 1994; Luscinskas et
in shear with VCAM-1 without exogenous stimulation, al., 1995), suggest that the multistep model of neutrophil
although stimulation can induce development of firm extravasation from the bloodstream needs to be refined
adhesion so that cells arrest rather than roll on VCAM- to apply to the extravasation process of T lymphocytes.
1. Thus, VLA-4 expressed on peripheral T lymphocytes T lymphocyte emigration from the bloodstream into
appears to exist in a constitutively active form and we chronic inflammatory sites appears initially to involve
found that addition of MCP-1 was seemingly unable to the cooperative and probably overlapping interactions
augment further T lymphocyte binding to VCAM-1. Data of both VLA-4 with VCAM-1, and selectins with their
on the effects of MCP-1 on T lymphocyte binding to FN, respective carbohydrate ligands. The combination of
however, clearly demonstrate that MCP-1-stimulated these interactions allows a T lymphocyte free in flow to
binding toFN is at least partially dependent on activation tether and roll on activated endothelium. We hypothe-
of the integrin VLA-4. Thus, it appears that MCP-1 is size that rolling T lymphocytes are able to arrest sponta-
only able to regulate some VLA-4 binding activities. This neously via a semiactivated form of VLA-4, or arrest via
finding is in agreement with work by other groups who b2 integrins in response to factors that remain to be
find that VLA-4 exists inmultiple activation states (Masu- identified. Currently identified chemokines may be most
moto and Hemler, 1993; Jakubowski et al., 1995). In the important for directional cues in transendothelial migra-
model proposed by Hemler and colleagues, VLA-4 is tion, migration through the basement membrane and
thought to exist in inactive, partially active, or fully active within tissue, and in regulating adhesion toECM compo-
states. In the inactive state, VLA-4 is unable to bind to nents. Transendothelial migration of T lymphocytes is
either of its two ligands, VCAM-1 or FN. In the partially inhibited by MAb to b2 integrins or in b2 integrin±
active state, it is only able to bind to VCAM-1, but not deficient patients (Oppenheimer-Marks et al., 1990,
FN, and, finally, in the fully activated state, VLA-4 is able 1991; van Kooyk et al., 1993; Kavanaugh et al., 1991;
to bind both ligands. Thus, binding to VCAM-1 requires Vennegoor et al., 1992) and it remains unclear what
a lower threshold of activation than does binding to FN. adhesive mechanism regulates the b2 integrin±depen-
dent extension of a pseudopod through the endothelialThis model, together with data presented here, supports
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were quantitated by analysis of images videotaped with a TEC-470layer to initiate the first contact with the subendothelial
CCD video camera (Optronics, Goleta, California) and a Mitsubishimatrix. However, once this contact is initiated, our data
HS-U67 VHS recorder. T lymphocytes (1 3 106 cells/ml) were resus-suggest that chemokine-stimulated adhesion to FN is
pended in binding buffer (HBSS, containing 10 mM HEPES [pH 7.4],
important in completion of transendothelial migration, 1 mM Mg21, 2 mM Ca21, and 2 mg/ml HSA) and perfused into the
as well as in migration through ECM in the basement flow chamber. When assessing the effects of soluble activators on
T lymphocyte adhesion, the activator was added directly to the cellmembrane and within tissues.
suspension seconds before being perfused. Perfused cells were
incubated under static conditions for 6.5 min at room temperature,Experimental Procedures
then flow was initiated and increased in 2- to 2.5-fold increments
every 10 s. The number of cells remaining bound at each intervalReagents
was determined by careful analysis of the video tape. The sameRecombinant human tumor necrosis factor-a (TNFa) was purchased
field of view was used for each substrate within each experimentfrom Genzyme (Cambridge, Massachusetts). Purified recombinant
to ensure that the results reflected uniform site density and distribu-human chemokines were purchased from Peprotech, Incorporated
tion of the immobilized protein. All adhesion experiments were per-(Rocky Hill, New Jersey) or R and D Systems (Minneapolis, Min-
formed a minimum of three times. PMA control is included in allnesota).
experiments and is considered to be indicative of the maximal num-
ber of cells capable of binding to a given substrate in a given experi-MAbs
ment. The data is expressed as the percent of statically interactingThe following previously described murine MAbs against human
cells that remained bound at each shear stress.antigens were used: B1 (anti-CD20, immunoglobulin G2a [IgG2a])
For inhibition studies, T lymphocytes were preincubated for 10(Stashenko et al., 1980) and MY4 (anti-CD14, IgG2b) (Griffin et al.,
min in binding buffer with 30 mg/ml of purified MAb or a 1:30 dilution1981) from Coulter Immunology (Hialeah, Florida). 3G8 (anti-CD16,
of ascites. The cell suspension was diluted in a 10-fold volume ofIgG1) (Fleit et al., 1989) from AMAC, Incorporated (Westbrook,
binding buffer containing antibody (with or without activator) andMaine). OKM1 (anti-CD11b, IgG2b) (Breard et al., 1980) from Ortho
immediately perfused into the flow chamber. GRGDSP and GRDESPDiagnostic Systems (Raritan, New Jersey). R6.5 (anti-ICAM-1,
peptides were preincubated with cells for 20 min at 300 mM priorIgG2a) (Smith et al., 1989) produced in our laboratory. A4-PUJ1
to infusion and were included in the buffer (with or without activator)(anti-CD49d, IgG1), A5-PUJ1 (anti-CD49e, IgG1), and MAb 13 (anti-
at the initiation of the assay. To test the effect of cytochalasin BCD29, IgG2a) (Akiyama et al., 1989) were gifts from Dr. M. Hemler
(CB), cells were incubated with cytochalasin B at a concentration(Dana Farber Cancer Institute, Boston, Massachusetts).
of 2 or 20 mM for 30 s at room temperature and perfused without
dilution (with or without activator) into the flow chamber. CB wasPreparation of PBL and T Lymphocytes
present in the binding buffer throughout the assay.Human peripheral blood mononuclear cells (PBMCs) were purified
from citrate-anticoaggulated whole blood of healthy volunteer do-
Statistical Analysisnors by dextran sedimentation and centrifugation through Ficoll±
Data was analyzed where indicated using a paired two-tailed stu-Hypaque (1.077) as previously described (English and Anderson,
dent's t test.1974). T lymphocytes were purified from PBMC by negative selec-
tion using magnetic cell separation (MACS, Miltenyi Biotec, Sun-
Acknowledgmentsnyvale, California) (Miltenyi et al., 1990). In brief, PBMCs were incu-
bated for 30 min on ice with 5 mg/ml of MAbs to B cells (B1), natural
The authors wish to thank E. Finger and Drs. R. Fuhlbrigge and S.killer cells (3G8), and monocytes (MY4 and OKM1). The PBMCs were
Roth for helpful discussions and critical reading of the manuscript.then washed and incubated with MACS rat anti-mouse IgG1 and
This work was supported by National Institutes of Health grantsIgG2a12b magnetic microbeads (Miltenyi Biotec). Following a 20
HL48675 and CA31798.min incubation on ice, cells were loaded onto a preeÈ quilibrated
magnetic separation column coupled to the MACS magnet. All T
Received September 21, 1995; revised January 3, 1996.lymphocyte purifications were done at 48C. T lymphocyte prepara-
tions routinely had >98% cell viability as determined by trypan blue
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Note Added in Proof
The information reported in the text as S.J. Roth, M.W.C., and T.A.S.
has since been published: Roth, S.J., Carr, M.W., and Springer,
T.A. (1995). C±C chemokines, but not the C±X±C chemokines in-
terleukin-8 and interferon g inducible protein-10, stimulate transen-
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